期刊文献+

眼球破裂伤早期玻璃体手术应用曲安奈德的临床分析 被引量:2

Clinical study the effects of early vitrectomy combined with triameinolone acetonide injection in vitreous cavity on rupture of the eyeballs
原文传递
导出
摘要 目的探讨眼球破裂伤早期玻璃体手术联合应用曲安奈德的疗效。方法眼球破裂伤一期手术修补眼球后早期行玻璃体手术时分为用药组(37例,37只眼)和对照组(39例,39只眼)。两组眼球破裂伤患者均一期手术修补眼球,术后7—14d行玻璃体手术。用药组术中向玻璃体腔注射曲安奈德,实施了可视化的玻璃体手术。结果眼球破裂伤早期玻璃体手术中玻璃体腔注射曲安奈德使得术中更能清楚的辨认玻璃体后皮质,视网膜前的增殖膜,内界膜等眼内组织。更好得完成人工的玻璃体后脱离,彻底清除玻璃体后皮质,减少了黄斑前玻璃体皮质残留所引起的并发症,术后炎症反应明显减轻。结论曲安奈德可以使得玻璃体可视化,提高了眼球破裂伤二次玻璃体手术的准确性与安全性,减少了术后的并发症,减轻了手术后的炎症反应。 Objective To explore the effects of early vitrectomy combined with triameinolone acetonide (TA) injection in vitreous cavity on rupture of the eyeballs. Methods The patients with rupture of the eyeballs after eye patch were divided into two groups, the medication group (37 cases, 37 eyes) and control group (39 cases, 39 eyes). Two group of ocular rupture sick and wounded received homogeneous time surgery patches the eyeball, they were operated with vitrectomy after 7-14days. Triameinolone acetonide made pellu- cid vitrectomy visible were injected into the medication group during the vitrectomy. Results In vitrectomy, intmoperative staining with TA consistently improved direct visualization and delineation of the posterior hyaloids, ERM or ILM, facilitated their removed. The method can perfectly accomplish the artificial posterior detachment of vitreous, completely eliminate perimeter vitreous, and reduce the complication aroused by re- maining vitreous before macula, at the same time the method can evidently reduce postoperative inflammatory reaction. Conclusions TA can make pellucid vitreetomy visible, rising the reliability of vitrectomy, reduce operative complication, and relieve postoperative inflammatory reaction.
出处 《中国实用眼科杂志》 CSCD 北大核心 2009年第12期1401-1403,共3页 Chinese Journal of Practical Ophthalmology
关键词 曲安奈德 玻璃体手术 眼球破裂伤 Triameinolone acetonide Vitrectomy Rupture of the eyeballs
  • 相关文献

参考文献15

  • 1Peyman GA, Cheema R, Conway MD, et al.Triamicinolone acetonide as an aid to visualization of the vitreous and posterior hyaloid during pars plana vitrectomy.Retina, 2000, 20: 554-555.
  • 2Tano Y, Chandler D, Machemer R.Treatment of intraocular proliferation with intravitreal injection of Triamcinolone-acetonide.Am J Ophthalmol, 1980, 90:810-816.
  • 3kazuyuki Kumagai.Introduction of a new method for the prearation of triamcinlone acetonide solution as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy.Retina, 2003, 23:881-882.
  • 4Schole GN, O'Brien WJ, Abrams GW, et al.Clearance of triamcinoline from vitreous.Arth Ophthalmol, 1985,103 : 1567-1569.
  • 5Schindler RH, Chandler D, Thresher R, et al.The clearance of intravitreal trimcinlone acetonide.Am J Ophthalmol, 1982, 93:415-417.
  • 6MeCuen BW, Bessler M, Tano Y, et al.The lask of toxicity of intravitreally administered triameinolone aeetonide,Am J Ophthalmol, 1981,91 : 785-788.
  • 7Gopal L--Bhende M, Sharma T.Vitrectomy for accidental intraoeular steroid injection.Retina, 1995, 15: 295-299.
  • 8Kivilcim M, Peyman GA, El-Dessouky ES, et al.Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.Ophthalmic Surg Lasers, 2000., 31:474-478.
  • 9Gillies M, Simpson JM, Billson FA, et al.Safety of an intravitreal injection of triamcinolone.Results from a randomized clinical trial.Arch Ophthalmol, 2004, 22:336-340.
  • 10坂本泰二.硝子体细胞の细胞生物学[J].日眼会志,2003,107:866-882.

二级参考文献4

  • 1Jost B. Jonas,Ingrid Kreissig,Robert F. Degenring. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(9):782~783
  • 2Taiji Sakamoto,Miho Miyazaki,Toshio Hisatomi,Takao Nakamura,Akifumi Ueno,Keiko Itaya,Tatsuro Ishibashi. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood–ocular barrier breakdown[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(6):423~429
  • 3Yu-sheng Wang,Ulrike Friedrichs,Wolfram Eichler,Stephan Hoffmann,Peter Wiedemann. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells[J] 2002,Graefe’s Archive for Clinical and Experimental Ophthalmology(1):42~48
  • 4Yan-Nian Hui,Hou-Cheng Liang,Yong-Shu Cai,Bernd Kirchhof,Klaus Heimann. Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretionopathy induced by macrophages[J] 1993,Graefe’s Archive for Clinical and Experimental Ophthalmology(2):109~114

共引文献89

同被引文献21

  • 1王小军,姚克,杜新华.严重眼外伤的玻璃体手术治疗[J].眼外伤职业眼病杂志,2005,27(6):406-408. 被引量:44
  • 2范传峰,朱晓华.外伤后早期眼球萎缩玻璃体手术的疗效分析[J].中国实用眼科杂志,2006,24(1):94-97. 被引量:8
  • 3赵堪兴,杨培增.眼科学.7版.北京:人民卫生出版社,2008.
  • 4施彩虹,朱鸿,蒋坚,沈泽民.复杂开放性眼外伤Ⅰ期修复的临床意义[J].上海交通大学学报(医学版),2007,27(8):930-932. 被引量:5
  • 5Kirehhd B. strategies to influence PVR development. Gades Arch clin EXP Ophthalmo1,2004 ,42 :699 - 703.
  • 6Coleman D J. Early vitrectomg in the management of the penetrating eye. Am J ophthalmol, 1982,93:543 - 551.
  • 7Bajaire B, Oudovichenko E, Morales E. Vitreoretinal surgery of the posterior segment for explosive trauma in terrorist warfare. Graefes Arch Clin EXP Ophthalmol,2006 ,244 :991 -995.
  • 8Schole GN, O' Brien WJ, Abrams GW, et al. Clearance of tramcinoline form vitreous. Arth Ophthalmol. 1985,103 : 1567 - 1569.
  • 9Ryan SJ,Allen AW. Pars plana vitrectomy in ocular trauma[ J ]. Am J Ophthalmol, 1979,88 ( 3Ptl ) :483-490.
  • 10Globocnik PM, Lumi X, Drnovsek OB. Prognostic factors in open eye injury managed with vitreoctomy: retrospective study [ J ]. Croat Med J,2004,45(3) :299-303.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部